CellaVision
251.5 SEK -1.18%1,502 investors are following this company
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Revenue
-
EBIT %
-
P/E
46.06
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
CEVI
Daily low / high price
250 / 255
SEK
Market cap
6B SEK
Turnover
943.41K SEK
Volume
3.7K
Latest videos
Financial calendar
Interim report
2024-10-24
Annual report
2025-02-06
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
William Demant Invest | 19.9 % | 19.9 % |
Grenlunden CEVI AB | 10.0 % | 10.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
![CellaVision, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/d7b70acb-042d-482f-82ad-adbc1f2e6132.png)
CellaVision, Audiocast with teleconference, Q2'24
Stabilt kvartal och tillväxt i APAC
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Solid Quarter and Growth in APAC
Inbjudan till presentation av CellaVisions rapport för andra kvartalet 2024, den 19 juli kl. 11:00
Invitation to Presentation of the CellaVision Report for the Second Quarter 2024 on July 19, at 11:00 CEST
Kommuniké från årsstämma i CellaVision AB (publ)
Bulletin from the Annual General Meeting of CellaVision AB (publ)
Redeye: Cellavision - Trend is still their friend
![CellaVision, Audiocast with teleconference, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/a68533b7-87f3-46d8-b49d-a765fa3c0fb8.png)
CellaVision, Audiocast with teleconference, Q1, 2024
Stabil start på året
A Solid Start to the Year
Inbjudan till presentation av CellaVisions rapport för första kvartalet 2024, den 25 april kl. 11:00
Invitation to Presentation of the CellaVision Report for the First Quarter 2024 on April 25, at 11:00 CEST
CellaVision publishes its 2023 Annual and Sustainability Report
CellaVision publicerar års- och hållbarhetsredovisning för 2023
NOTICE OF ANNUAL GENERAL MEETING IN CELLAVISION AB (publ)
KALLELSE TILL ÅRSSTÄMMA i CELLAVISION AB (PUBL)
Redeye: Cellavision Q4 - Firing on all cylinders towards the year-end
![CellaVision, Audiocast with teleconference, Q4, 2023](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/cc15b888-9b5c-44d8-a5ec-801257bdbed9.png)